Statewide Variance of Chapters HFS
124 and HFS 83, Wisconsin Administrative Code, Mantoux Tuberculin Skin
Test
***Effective Immediately***
PDF Version of BQA 06-009 (PDF
34 KB)
To: Hospitals
HOSP - 07,
Community Based Residential Facilities
CBRF
- 05
Date: June 6, 2006 -- DDES-BQA 06-009
FROM: Jan Eakins, Section Chief, Provider
Regulation and Quality Improvement
Via: Otis Woods, Director, Bureau of Quality Assurance
The purpose of this statewide variance is to provide an alternative
test for the identification of tuberculosis infection.
Background
The state rules governing the Mantoux Skin Test are found in Chapters
HFS 124 and 83.
Chapter HFS 124 Hospitals
HFS 124.07(2)(c) states: A Mantoux tuberculin skin test consisting of 5
tuberculin units (TU) of purified protein derivative (PPD) and, if
necessary, a chest roentgenogram to determine whether disease is present,
unless medically contraindicated. Persons with positive findings shall be
referred to a physician for evaluation.
Chapter HFS 83 Community Based Residential Facilities
HFS 83.33(2)(g)(1)(b) states: The screening for communicable disease
shall include a tuberculin skin test using the Mantoux 5TU PPD test and a
visual screening for other clinically apparent communicable diseases.
On May 2, 2005 The Federal Drug Administration (FDA) approved the
QuantiFERON -TB GOLD blood test as another method to screen for active
tuberculosis (TB) or latent tuberculosis infection (LTBI). It is a whole
blood test and does not require a return visit to determine results. On
December 16, 2005, CDC published "Guidelines for Using the
QuantiFERON®-TB Gold Test for Detecting Mycobacterium tuberculosis
Infection, United States" MMWR, Recommendations and Reports,
54(RR15);49-54 and it can be found at http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5415a4.htm
Action
A statewide variance, from the two state rules listed above, is being
granted to include QuantiFERON -TB GOLD as an alternative test for
Tuberculosis.
The use of this variance must not jeopardize the health, safety or
welfare of any patient or resident. The Department reserves the right to
review, revise or revoke any and all variances at any time.
Please contact Gail Hansen at (608) 266-2966 or at hansege@dhfs.state.wi.us
if you have any questions or need additional clarification.
PDF: The free Acrobat Reader®
software is needed to view and print portable document format (PDF) files.
Learn more. |
